Vladimir B. Arion

Structure−Activity Relationships for NAMI-A-type Complexes (HL)[<i>trans</i>-RuCl₄L(<i>S</i>-dmso)ruthenate(III)] (L = Imidazole, Indazole, 1,2,4-Triazole, 4-Amino-1,2,4-triazole, and 1-Methyl-1,2,4-triazole):  Aquation, Redox Properties, Protein Binding, and Antiproliferative Activity

Michael Groessl, Erwin Reisner, Christian G. Hartinger et al. · Journal of Medicinal Chemistry · 2007 · 212 citations

Nami-a-type Complexes, Chemistry, Pharmaceutical Chemistry +16

Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

M. Pongratz, Petra Schluga, Michael A. Jakupec et al. · Journal of Analytical Atomic Spectrometry · 2004 · 203 citations

Molecular Biology, Chemical Biology, Cancer Biology +25

Electron-transfer activated metal-based anticancer drugs

Erwin Reisner, Vladimir B. Arion, Bernhard K. Keppler et al. · Inorganica Chimica Acta · 2006 · 196 citations

Nanomedicine, Medicinal Chemistry, Polymer-drug Conjugate +5

Tuning of Redox Potentials for the Design of Ruthenium Anticancer Drugs − an Electrochemical Study of [<i>trans</i>-RuCl₄L(DM<i>S</i>O)]^- and [<i>trans</i>-RuCl₄L₂]^- Complexes, where L = Imidazole, 1,2,4-Triazole, Indazole

Erwin Reisner, Vladimir B. Arion, M. Fátima C. Guedes da Silva et al. · Inorganic Chemistry · 2004 · 169 citations

Redox-Active Antineoplastic Ruthenium Complexes with Indazole:  Correlation of in Vitro Potency and Reduction Potential

Michael A. Jakupec, Erwin Reisner, Anna Eichinger et al. · Journal of Medicinal Chemistry · 2005 · 164 citations